Individual ages in a are ±1σ.
From this list, one individual aged between 18 and 65 years, male or female, was randomly selected as the participant in the study.
The predictor variables of this analysis were individual, age and intensity.
This level of individual age subgroup analysis is consistent with recent FDA guidelines.
Understanding whether this reflects differences in individual aging rates, or the action of different mechanisms of aging in different subsets of a population is unknown and will require the characterization of aging at the level of the individual.
We did not see any significant protection for treatment at a pediatric hospital or pediatric-affiliated hospital in the group for which we included this variable, individuals aged 0 14.
The fraction of cases prevented is not equivalent across age groups with this strategy: individuals aged 0-4 and ≥55 years experience the largest relative reduction in final attack rate (18% decrease), while those in the 5-17 agroupoup have the smallest (10% decrease).
(c Special rule: Individual age 65 or over.
This analysis is restricted to individuals aged 15 59 years; therefore, care should be taken in extrapolating results to individual aged below 15 years and above 60 years.
Point A marks the midpoint in life for this individual, at chronological age 50 (red line, labelled), and thanatological age 50 (green line).
